LC
BNGO icon

Lindbrook Capital’s Bionano Genomics BNGO Stock Holding History

Lindbrook Capital’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2
Closed -$1.35K – 2731
2023
Q1 		$1.35K Buy
+2
New +$1.78K ﹤0.01% 2386
2022
Q4 		– Sell
-1
Closed -$1K – 2847
2022
Q3 		$1K Buy
+1
New +$1.32K ﹤0.01% 2250

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lindbrook Capital's BNGO Position: Q2 2023 in Review

Lindbrook Capital sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 2 shares — an estimated $1.35K sold.

Lindbrook Capital first reported a position in BNGO in Q3 2022 and held it in 2 quarters. The position peaked at $1.35K in Q1 2023. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Lindbrook Capital reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Lindbrook Capital sold 2 Bionano Genomics shares in Q2 2023, an estimated $1.35K.
  • Lindbrook Capital first reported a position in Bionano Genomics in Q3 2022 and held it in 2 quarters.
  • Lindbrook Capital's Bionano Genomics position peaked at $1.35K in Q1 2023.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.